200 related articles for article (PubMed ID: 1967857)
1. Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.
Neubauer BL; Goode RL; Best KL; Hirsch KS; Lin TM; Pioch RP; Probst KS; Tinsley FC; Shaar CJ
Toxicol Appl Pharmacol; 1990 Feb; 102(2):219-32. PubMed ID: 1967857
[TBL] [Abstract][Full Text] [Related]
2. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
Lin TM; Evans DC; Warrick MW; Pioch RP
J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
[TBL] [Abstract][Full Text] [Related]
3. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
[TBL] [Abstract][Full Text] [Related]
4. The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro.
Sivelle PC; Underwood AH; Jelly JA
Biochem Pharmacol; 1982 Mar; 31(5):677-84. PubMed ID: 6123322
[TBL] [Abstract][Full Text] [Related]
5. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
[TBL] [Abstract][Full Text] [Related]
6. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
Hammond JB; Offen WW
Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo comparisons of antiandrogenic potencies of two histamine H2-receptor antagonists, cimetidine and etintidine--HCl.
Foldesy RG; Vanderhoof MM; Hahn DW
Proc Soc Exp Biol Med; 1985 Jun; 179(2):206-10. PubMed ID: 2859600
[TBL] [Abstract][Full Text] [Related]
8. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
10. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
11. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
Takagi T; Takeda M; Maeno H
Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of oral nizatidine.
Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
14. Antiprostatic effect of cimetidine in rats.
Pinelli P; Trivulzio S; Colombo R; Cocchi D; Faravelli R; Caviezel F; Galmozzi G; Cavallaro R
Agents Actions; 1987 Dec; 22(3-4):197-201. PubMed ID: 3445815
[TBL] [Abstract][Full Text] [Related]
15. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
[TBL] [Abstract][Full Text] [Related]
16. The 24-hour acid suppression profile of nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the anti-androgen effects associated with H2 antagonist therapy.
Van Thiel DH; Gavaler JS; Heyl A; Susen B
Scand J Gastroenterol Suppl; 1987; 136():24-8. PubMed ID: 2892252
[TBL] [Abstract][Full Text] [Related]
18. Effect of a new potent H2-blocker, 3-[[[2-(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats.
Takeda M; Takagi T; Yashima Y; Maeno H
Arzneimittelforschung; 1982; 32(7):734-7. PubMed ID: 6127086
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
20. Do nizatidine and cimetidine interact with ibuprofen?
Forsyth DR; Jayasinghe KS; Roberts CJ
Eur J Clin Pharmacol; 1988; 35(1):85-8. PubMed ID: 2905991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
